🚀 VC round data is live in beta, check it out!
Nutriband Valuation Multiples
Discover revenue and EBITDA valuation multiples for Nutriband and similar public comparables like Pentixapharm Holding, HeartBeam, Envoy Medical, Modulight and more.
Nutriband Overview
About Nutriband
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Founded
2016
HQ
Employees
13
Website
Sectors
Financials (FY)
EV
$49M
Nutriband Financials
Nutriband reported last fiscal year revenue of $2M and negative EBITDA of ($10M).
In the same fiscal year, Nutriband generated $743K in gross profit, ($10M) in EBITDA losses, and had net loss of ($10M).
Revenue (LTM)
Nutriband P&L
In the most recent fiscal year, Nutriband reported revenue of $2M and EBITDA of ($10M).
Nutriband expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $2M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $743K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 32% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($10M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (443%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (291%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($10M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (456%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Nutriband Stock Performance
Nutriband has current market cap of $54M, and enterprise value of $49M.
Market Cap Evolution
Nutriband's stock price is $4.43.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $49M | $54M | 0.0% | XXX | XXX | XXX | $-0.86 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNutriband Valuation Multiples
Nutriband trades at 21.3x EV/Revenue multiple, and (4.8x) EV/EBITDA.
EV / Revenue (LTM)
Nutriband Financial Valuation Multiples
As of March 21, 2026, Nutriband has market cap of $54M and EV of $49M.
Equity research analysts estimate Nutriband's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Nutriband has a P/E ratio of (5.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $54M | XXX | $54M | XXX | XXX | XXX |
| EV (current) | $49M | XXX | $49M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 21.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (4.8x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (7.3x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 65.8x | XXX | XXX | XXX |
| P/E | — | XXX | (5.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (10.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Nutriband Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Nutriband Margins & Growth Rates
Nutriband's revenue in the last fiscal year grew by 0%.
Nutriband Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 0% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (443%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 4% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 136% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 324% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Nutriband Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Pentixapharm Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| HeartBeam | XXX | XXX | XXX | XXX | XXX | XXX |
| Envoy Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Modulight | XXX | XXX | XXX | XXX | XXX | XXX |
| Svas Biosana | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Nutriband M&A Activity
Nutriband acquired XXX companies to date.
Last acquisition by Nutriband was on XXXXXXXX, XXXXX. Nutriband acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Nutriband
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNutriband Investment Activity
Nutriband invested in XXX companies to date.
Nutriband made its latest investment on XXXXXXXX, XXXXX. Nutriband invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Nutriband
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Nutriband
| When was Nutriband founded? | Nutriband was founded in 2016. |
| Where is Nutriband headquartered? | Nutriband is headquartered in United States. |
| How many employees does Nutriband have? | As of today, Nutriband has over 13 employees. |
| Who is the CEO of Nutriband? | Nutriband's CEO is Gareth Sheridan. |
| Is Nutriband publicly listed? | Yes, Nutriband is a public company listed on Nasdaq. |
| What is the stock symbol of Nutriband? | Nutriband trades under NTRB ticker. |
| When did Nutriband go public? | Nutriband went public in 2017. |
| Who are competitors of Nutriband? | Nutriband main competitors are Pentixapharm Holding, HeartBeam, Envoy Medical, Modulight. |
| What is the current market cap of Nutriband? | Nutriband's current market cap is $54M. |
| What is the current revenue of Nutriband? | Nutriband's last fiscal year revenue is $2M. |
| What is the current EV/Revenue multiple of Nutriband? | Current revenue multiple of Nutriband is 21.3x. |
| Is Nutriband profitable? | No, Nutriband is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.